In the TCGA cohort, 29% of HNSCC tumours have at least one component of COX-2-PGE2 pathway transcriptionally activated, mostly PGE2 synthases or PGE2 receptors (Fig. 3F). This evidence concerns the gene PTGS2 and neoplasm.